PF-3758309 (Synonyms: PF-03758309)

Name: PF-3758309
Brand: MedChemExpress
SKU: HY-13007
Rating: 5.0 (10 reviews)

Cat. No.: HY-13007 Purity: 99.79%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

PF-3758309 (PF-03758309) is a potent, orally available, and reversible ATP-competitive inhibitor of PAK4 (K_d= 2.7 nM; K_i=18.7 nM). PF-3758309 has the expected cellular functions of a PAK4 inhibitor: inhibition of anchorage-independent growth, induction of apoptosis, cytoskeletal remodeling, and inhibition of proliferation.

For research use only. We do not sell to patients.

PF-3758309 Chemical Structure

CAS No. : 898044-15-0

Size	Stock	Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	In-stock	Estimated Time of Arrival: December 31
Solid
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	In-stock	Estimated Time of Arrival: December 31
25 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	In-stock	Estimated Time of Arrival: December 31
100 mg	In-stock	Estimated Time of Arrival: December 31
200 mg	Get quote
500 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 10 publication(s) in Google Scholar

Other Forms of PF-3758309:

PF-3758309 hydrochloride Get quote
PF-3758309 dihydrochloride Get quote

10 Publications Citing Use of MCE PF-3758309

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All PAK Isoform Specific Products:

View All Isoforms

PAK1 PAK2 PAK3 PAK4 PAK5 PAK6

Biological Activity
Purity & Documentation
References
Customer Review

Description

IC₅₀ & Target^[1]

PAK4

18.7 nM (Ki)

PAK1

13.7 nM (Ki)

PAK5

18.1 nM (Ki)

PAK6

17.1 nM (Ki)

PAK2

190 nM (IC₅₀)

PAK3

99 nM (IC₅₀)

PAK4

2.7 nM (Kd)

Cellular Effect

Cell Line	Type	Value	Description	References
A549	IC₅₀	0.463 μM Compound: PF-3758309	Antiproliferative activity against human A549 cells after 72 hrs by CCK8 assay Antiproliferative activity against human A549 cells after 72 hrs by CCK8 assay	[PMID: 29886323]
A549	IC₅₀	0.67 μM Compound: 1; PF-3758309	Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay	[PMID: 37864885]
A549	IC₅₀	20 nM Compound: 1; PF-3758309	Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 3 days by CellTiter-Glo luminescent cell viability assay Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 3 days by CellTiter-Glo luminescent cell viability assay	[PMID: 37864885]
A549	IC₅₀	20 nM Compound: PF-3758309	Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
A549	IC₅₀	27.38 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human A549 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human A549 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
ASPC1	IC₅₀	1800 nM Compound: PF-3758309	Antiproliferative activity against human ASPC1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human ASPC1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
BT-20	IC₅₀	81.7 nM Compound: PF-3758309	Antiproliferative activity against human BT-20 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human BT-20 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
BT-474	IC₅₀	1.8 nM Compound: PF-3758309	Antiproliferative activity against human BT-474 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human BT-474 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
BT-549	IC₅₀	0.41 nM Compound: PF-3758309	Antiproliferative activity against human BT-549 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human BT-549 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
BXPC-3	IC₅₀	39 nM Compound: PF-3758309	Antiproliferative activity against human BXPC-3 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human BXPC-3 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
CAMA-1	IC₅₀	2.7 nM Compound: PF-3758309	Antiproliferative activity against human CAMA-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human CAMA-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
CAPAN-1	IC₅₀	1099 nM Compound: PF-3758309	Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
CFPAC-1	IC₅₀	1320 nM Compound: PF-3758309	Antiproliferative activity against human CFPAC-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human CFPAC-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
COLO 205	IC₅₀	140.2 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human COLO 205 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human COLO 205 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
COLO 205	IC₅₀	2.8 nM Compound: PF-3758309	Antiproliferative activity against human COLO 205 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human COLO 205 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
COLO 320DM	IC₅₀	205 nM Compound: PF-3758309	Antiproliferative activity against human COLO 320DM cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human COLO 320DM cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
COLO 320DM	IC₅₀	373.4 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human COLO 320DM cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human COLO 320DM cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
Caco-2	IC₅₀	10000 nM Compound: PF-3758309	Antiproliferative activity against human Caco-2 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human Caco-2 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
Calu-1	IC₅₀	167 nM Compound: PF-3758309	Antiproliferative activity against human Calu-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human Calu-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
Calu-6	IC₅₀	7.3 nM Compound: PF-3758309	Antiproliferative activity against human Calu-6 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human Calu-6 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
Capan-2	IC₅₀	136 nM Compound: PF-3758309	Antiproliferative activity against human Capan-2 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human Capan-2 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
DAN-G	IC₅₀	518 nM Compound: PF-3758309	Antiproliferative activity against human DAN-G cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human DAN-G cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
DLD-1	IC₅₀	10000 nM Compound: PF-3758309	Antiproliferative activity against human DLD-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human DLD-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HCC1187	IC₅₀	0.24 nM Compound: PF-3758309	Antiproliferative activity against human HCC1187 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HCC1187 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HCC1395	IC₅₀	1.6 nM Compound: PF-3758309	Antiproliferative activity against human HCC1395 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HCC1395 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HCC1419	IC₅₀	0.79 nM Compound: PF-3758309	Antiproliferative activity against human HCC1419 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HCC1419 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HCC1806	IC₅₀	1.2 nM Compound: PF-3758309	Antiproliferative activity against human HCC1806 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HCC1806 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HCC1954	IC₅₀	0.33 nM Compound: PF-3758309	Antiproliferative activity against human HCC1954 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HCC1954 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HCC38	IC₅₀	0.52 nM Compound: PF-3758309	Antiproliferative activity against human HCC38 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HCC38 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HCC4006	IC₅₀	3.79 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human HCC4006 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human HCC4006 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
HCC70	IC₅₀	0.23 nM Compound: PF-3758309	Antiproliferative activity against human HCC70 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HCC70 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HCC827	IC₅₀	2.18 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human HCC827 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human HCC827 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
HCC827	IC₅₀	9.2 nM Compound: PF-3758309	Antiproliferative activity against human HCC827 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HCC827 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HCT-116	IC₅₀	0.039 μM Compound: PF-3758309	Antiproliferative activity against human HCT116 cells after 72 hrs by CCK8 assay Antiproliferative activity against human HCT116 cells after 72 hrs by CCK8 assay	[PMID: 29886323]
HCT-116	IC₅₀	0.24 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human HCT-116 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human HCT-116 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
HCT-116	IC₅₀	2.4 nM Compound: PF-3758309	Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HCT-15	IC₅₀	10000 nM Compound: PF-3758309	Antiproliferative activity against human HCT-15 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HCT-15 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HEK-293T	IC₅₀	> 10 μM Compound: 1; PF-3758309	Antiproliferative activity against HEK293T cells assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay Antiproliferative activity against HEK293T cells assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay	[PMID: 37864885]
HPAC	IC₅₀	265 nM Compound: PF-3758309	Antiproliferative activity against human HPAC cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HPAC cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HPAF-II	IC₅₀	517 nM Compound: PF-3758309	Antiproliferative activity against human HPAF-II cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HPAF-II cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HT-29	IC₅₀	4.3 nM Compound: PF-3758309	Antiproliferative activity against human HT-29 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HT-29 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
Hepatocyte	IC₅₀	> 1000 nM Compound: PF-3758309	Cytotoxicity against primary hepatocyte (unknown origin) assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Cytotoxicity against primary hepatocyte (unknown origin) assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
Hs 766	IC₅₀	416 nM Compound: PF-3758309	Antiproliferative activity against human Hs766T cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human Hs766T cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
Hs-578T	IC₅₀	0.37 nM Compound: PF-3758309	Antiproliferative activity against human Hs-578T cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human Hs-578T cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HuP-T3	IC₅₀	280 nM Compound: PF-3758309	Antiproliferative activity against human HuP-T3 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HuP-T3 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
HuP-T4	IC₅₀	231 nM Compound: PF-3758309	Antiproliferative activity against human HuP-T4 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human HuP-T4 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
LS-123	IC₅₀	10000 nM Compound: PF-3758309	Antiproliferative activity against human LS-123 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human LS-123 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
LS174T	IC₅₀	7.2 nM Compound: PF-3758309	Antiproliferative activity against human LS174T cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human LS174T cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
MCF10	IC₅₀	0.21 nM Compound: PF-3758309	Antiproliferative activity against human MCF10 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human MCF10 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
MCF7	IC₅₀	44.6 nM Compound: PF-3758309	Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
MDA-MB-157	IC₅₀	145 nM Compound: PF-3758309	Antiproliferative activity against human MDA-MB-157 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human MDA-MB-157 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
MDA-MB-361	IC₅₀	6.9 nM Compound: PF-3758309	Antiproliferative activity against human MDA-MB-361 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human MDA-MB-361 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
MDA-MB-415	IC₅₀	36 nM Compound: PF-3758309	Antiproliferative activity against human MDA-MB-415 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human MDA-MB-415 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
MDA-MB-436	IC₅₀	0.79 nM Compound: 1, PF-3758309	Cytotoxicity against human MDA-MB-436 cells assessed as reduction in cell viability after 24 to 48 hrs by Celltiter-glo luminescence assay Cytotoxicity against human MDA-MB-436 cells assessed as reduction in cell viability after 24 to 48 hrs by Celltiter-glo luminescence assay	[PMID: 24432870]
MDA-MB-436	IC₅₀	0.79 nM Compound: PF-3758309	Antiproliferative activity against human MDA-MB-436 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human MDA-MB-436 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
MDA-MB-453	IC₅₀	13.3 nM Compound: PF-3758309	Antiproliferative activity against human MDA-MB-453 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human MDA-MB-453 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
MDA-MB-468	IC₅₀	0.63 nM Compound: PF-3758309	Antiproliferative activity against human MDA-MB-468 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human MDA-MB-468 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
MIA PaCa-2	IC₅₀	17 nM Compound: PF-3758309	Antiproliferative activity against human MIA PaCa-2 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human MIA PaCa-2 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H1299	IC₅₀	7 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H1299 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H1299 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H1355	IC₅₀	14.2 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H1355 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H1355 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H1395	IC₅₀	6.4 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H1395 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H1395 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H1395	IC₅₀	7.62 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H1395 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H1395 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H1437	IC₅₀	4.8 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H1437 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H1437 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H1573	IC₅₀	2.37 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H1573 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H1573 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H1573	IC₅₀	22 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H1573 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H1573 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H1581	IC₅₀	0.6 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H1581 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H1581 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H1650	IC₅₀	5.57 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H1650 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H1650 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H1651	IC₅₀	20 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H1651 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H1651 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H1666	IC₅₀	3.8 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H1666 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H1666 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H1666	IC₅₀	6.25 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H1666 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H1666 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H1703	IC₅₀	4.4 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H1703 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H1703 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H1734	IC₅₀	4.1 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H1734 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H1734 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H1755	IC₅₀	15 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H1755 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H1755 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H1770	IC₅₀	1.84 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H1770 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H1770 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H1838	IC₅₀	5.5 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H1838 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H1838 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H1838	IC₅₀	9.59 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H1838 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H1838 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H1975	IC₅₀	17 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H1975 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H1975 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H1993	IC₅₀	11.95 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H1993 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H1993 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H2087	IC₅₀	1.36 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H2087 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H2087 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H2087	IC₅₀	4.3 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H2087 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H2087 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H2170	IC₅₀	6.04 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H2170 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H2170 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H226	IC₅₀	9.3 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H226 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H226 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H23	IC₅₀	25 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H23 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H23 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H23	IC₅₀	3.45 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H23 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H23 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H2347	IC₅₀	2 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H2347 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H2347 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H358	IC₅₀	11 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H358 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H358 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H358	IC₅₀	7.7 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H358 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H358 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H441	IC₅₀	9.2 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H441 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H441 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H520	IC₅₀	1.13 nM Compound: PF-3758309	Inhibition of anchorage independent cell growth in human NCI-H520 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis Inhibition of anchorage independent cell growth in human NCI-H520 cells incubated for 6 days by Alamar blue reagent based fluorescence plate reader analysis	[PMID: 20439741]
NCI-H520	IC₅₀	5.6 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H520 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H520 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H526	IC₅₀	1.4 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H526 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H526 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H647	IC₅₀	36 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H647 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H647 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H716	IC₅₀	11 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H716 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H716 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
NCI-H82	IC₅₀	2.1 nM Compound: PF-3758309	Antiproliferative activity against human NCI-H82 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human NCI-H82 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
PANC-03-27	IC₅₀	32 nM Compound: PF-3758309	Antiproliferative activity against human PANC-03-27 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human PANC-03-27 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
PANC-08-13	IC₅₀	12 nM Compound: PF-3758309	Antiproliferative activity against human PANC-08-13 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human PANC-08-13 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
PANC-1	IC₅₀	856 nM Compound: PF-3758309	Antiproliferative activity against human PANC-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human PANC-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
PSN1	IC₅₀	34 nM Compound: PF-3758309	Antiproliferative activity against human PSN1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human PSN1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
PaTu 8988t	IC₅₀	73 nM Compound: PF-3758309	Antiproliferative activity against human PaTu 8988t cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent cell viability assay Antiproliferative activity against human PaTu 8988t cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent cell viability assay	[PMID: 20439741]
Panc1005	IC₅₀	67 nM Compound: PF-3758309	Antiproliferative activity against human Panc1005 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human Panc1005 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
RKO	IC₅₀	1.8 nM Compound: PF-3758309	Antiproliferative activity against human RKO cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human RKO cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
SK-BR-3	IC₅₀	132 nM Compound: PF-3758309	Antiproliferative activity against human SK-BR-3 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human SK-BR-3 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
SK-MES-1	IC₅₀	3.2 nM Compound: PF-3758309	Antiproliferative activity against human SK-MES-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human SK-MES-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
SU.86.86	IC₅₀	898 nM Compound: PF-3758309	Antiproliferative activity against human SU-86-86 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human SU-86-86 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
SW-620	IC₅₀	5.7 nM Compound: PF-3758309	Antiproliferative activity against human SW620 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human SW620 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
SW1990	IC₅₀	127 nM Compound: PF-3758309	Antiproliferative activity against human SW1990 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human SW1990 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
SW948	IC₅₀	4.3 nM Compound: PF-3758309	Antiproliferative activity against human SW948 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human SW948 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
T47D	IC₅₀	0.99 nM Compound: PF-3758309	Antiproliferative activity against human T47D cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human T47D cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
T84	IC₅₀	89 nM Compound: PF-3758309	Antiproliferative activity against human T84 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human T84 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]
ZR-75-1	IC₅₀	0.49 nM Compound: PF-3758309	Antiproliferative activity against human ZR-75-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay Antiproliferative activity against human ZR-75-1 cells assessed as inhibition of cell proliferation incubated for 3 days by CellTiter-Glo Luminescent Cell Viability Assay	[PMID: 20439741]

In Vitro

PF-3758309 has similar enzymatic potency against the kinase domains of the other group B PAKs (PAK5, K_i=18.1 nM; PAK6, K_i=17.1 nM) and group A PAK1 (K_i=13.7 nM), but is less active against the other two group A PAKs (PAK2, IC₅₀=190 nM; PAK3, IC₅₀=99 nM)^[1].
In cells, PF-3758309 inhibits phosphorylation of the PAK4 substrate GEF-H1 (IC₅₀=1.3 nM) and anchorage-independent growth of a panel of tumor cell lines (IC₅₀=4.7 nM)^[1].
PF-3758309 also inhibits endogenous pGEF-H1 accumulation in HCT116 cells. PF-3758309 potently inhibits cellular proliferation (IC₅₀=20 nM) and anchorage-independent growth (IC₅₀=27 nM) of A549 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

PF-3758309 (7.5-30 mg/kg; p.o.; twice daily for 9-18 days) results in statistically significant tumor growth inhibition (TGI) in HCT116 and A549 models^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Female nu/nu, CRL breed 6–8 weeks old mice (bearing HCT116 and A549 tumors)^[1]
Dosage:	7.5-30 mg/kg
Administration:	Oral administration; twice daily for 9-18 days
Result:	Significant tumor growth inhibition (TGI) in HCT116 and A549 models.

Clinical Trial

Molecular Weight

490.62

Formula

C₂₅H₃₀N₈OS

CAS No.

898044-15-0

Appearance

Solid

Color

White to light yellow

SMILES

CC1=NC2=C(SC=C2)C(NC3=NNC4=C3CN(C(N[C@@H](C5=CC=CC=C5)CN(C)C)=O)C4(C)C)=N1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	2 years
	-20°C	1 year

Solvent & Solubility

In Vitro:

DMSO : ≥ 100 mg/mL (203.82 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.0382 mL	10.1912 mL	20.3824 mL
5 mM	0.4076 mL	2.0382 mL	4.0765 mL
10 mM	0.2038 mL	1.0191 mL	2.0382 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (5.10 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (5.10 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (5.10 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 99.79%

Select Batch:

Data Sheet (284 KB) SDS (393 KB)

COA (256 KB) HNMR (440 KB) LCMS (94 KB)

Handling Instructions (2659 KB)

References

[1]. Murray, Brion W., et al. Small-molecule p21-activated kinase inhibitor PF3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proceedings of the National Academy of Sciences of the United States of America (2010), 107(20), 9446-9451, S94 [Content Brief]

[2]. Zhao ZS, et al. Do PAKs make good drug targets? F1000 Biol Rep. 2010 Sep 23;2:70. [Content Brief]

[3]. Ryu BJ, et al. PF-3758309, p21-activated kinase 4 inhibitor, suppresses migration and invasion of A549 human lung cancer cells via regulation of CREB, NF-κB, and β-catenin signalings. Mol Cell Biochem. 2014 Apr;389(1-2):69-77. [Content Brief]

[4]. Pitts TM, et al. Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer models. Front Pharmacol. 2013 Mar 28;4:35. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.0382 mL	10.1912 mL	20.3824 mL	50.9559 mL
	5 mM	0.4076 mL	2.0382 mL	4.0765 mL	10.1912 mL
	10 mM	0.2038 mL	1.0191 mL	2.0382 mL	5.0956 mL
	15 mM	0.1359 mL	0.6794 mL	1.3588 mL	3.3971 mL
	20 mM	0.1019 mL	0.5096 mL	1.0191 mL	2.5478 mL
	25 mM	0.0815 mL	0.4076 mL	0.8153 mL	2.0382 mL
	30 mM	0.0679 mL	0.3397 mL	0.6794 mL	1.6985 mL
	40 mM	0.0510 mL	0.2548 mL	0.5096 mL	1.2739 mL
	50 mM	0.0408 mL	0.2038 mL	0.4076 mL	1.0191 mL
	60 mM	0.0340 mL	0.1699 mL	0.3397 mL	0.8493 mL
	80 mM	0.0255 mL	0.1274 mL	0.2548 mL	0.6369 mL
	100 mM	0.0204 mL	0.1019 mL	0.2038 mL	0.5096 mL

PF-3758309 Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Please select a local distributor ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Product Name			Requested Quantity *
Applicant Name *			Salutation
Email Address *			Phone Number *
Department			Organization Name *
City			State
Country or Region *
Remarks

Product Name			Lot #
Applicant Name *			Email Address *
Phone Number			Department *
Organization Name *			Country or Region *
Remarks

PF-3758309 (Synonyms: PF-03758309)

Customer Review

Other Forms of PF-3758309:

10 Publications Citing Use of MCE PF-3758309

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All PAK Isoform Specific Products:

Biological Activity

Purity & Documentation

References

Customer Review

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

PF-3758309 Related Classifications

Keywords:

Your Recently Viewed Products:

Name
Email *

	Sorry, but the email address you supplied was invalid.

PF-3758309 (Synonyms: PF-03758309)

Customer Review

Other Forms of PF-3758309:

PF-3758309 Related Antibodies

10 Publications Citing Use of MCE PF-3758309

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All PAK Isoform Specific Products:

Biological Activity

Purity & Documentation

References

Customer Review

PF-3758309 Related Antibodies

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

PF-3758309 Related Classifications

Keywords:

Your Recently Viewed Products:

Customer Review

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report